Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Critical Care Explorations
|
September 28, 2020
Placenta-Derived Cell Therapy to Treat Patients With Respiratory Failure Due to Coronavirus Disease 2019
Ravit Barkama, Ami Mayo, Alona Paz, et al.
Antimicrobial Agents and Chemotherapy
|
September 15, 2010
National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases
Dror Marchaim, Tamar Gottesman, Orna Schwartz, et al.
Journal of Inherited Metabolic Disease
|
March 6, 2019
Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1-year Phase 1/2 clinical trial
Raphael Schiffmann, Ozlem Goker-Alpan, Myrl Holida, et al.
Diagnostic Microbiology and Infectious Disease
|
July 19, 2011
Pseudomonas aeruginosa bacteremia upon hospital admission: risk factors for mortality and influence of inadequate empirical antimicrobial therapy
Vered Schechner, Tamar Gottesman, Orna Schwartz, et al.
Eclinicalmedicine
|
September 14, 2020
Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma
Yasmin Maor, Daniel Cohen, Nir Paran, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
September 2, 2022
Monkeypox DNA levels correlate with virus infectivity in clinical samples, Israel, 2022
Nir Paran, Yfat Yahalom-Ronen, Ohad Shifman, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Critical Care Explorations
|
September 28, 2020
Placenta-Derived Cell Therapy to Treat Patients With Respiratory Failure Due to Coronavirus Disease 2019
Ravit Barkama, Ami Mayo, Alona Paz, et al.
Antimicrobial Agents and Chemotherapy
|
September 15, 2010
National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases
Dror Marchaim, Tamar Gottesman, Orna Schwartz, et al.
Journal of Inherited Metabolic Disease
|
March 6, 2019
Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1-year Phase 1/2 clinical trial
Raphael Schiffmann, Ozlem Goker-Alpan, Myrl Holida, et al.
Diagnostic Microbiology and Infectious Disease
|
July 19, 2011
Pseudomonas aeruginosa bacteremia upon hospital admission: risk factors for mortality and influence of inadequate empirical antimicrobial therapy
Vered Schechner, Tamar Gottesman, Orna Schwartz, et al.
Eclinicalmedicine
|
September 14, 2020
Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma
Yasmin Maor, Daniel Cohen, Nir Paran, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
September 2, 2022
Monkeypox DNA levels correlate with virus infectivity in clinical samples, Israel, 2022
Nir Paran, Yfat Yahalom-Ronen, Ohad Shifman, et al.
Page
of 4